Crossing the Blood-Brain Barrier for Neuroprotection: A Conceptual Review and Therapeutic Hypothesis on Exosome-Mediated Neuroglobin (NGB) Delivery in Alzheimer's and Parkinson's Diseases

Neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD), represent an escalating global health crisis characterized by progressive neuronal loss, oxidative stress, mitochondrial dysfunction, and pathological protein aggregation. Neuroglobin (NGB), an endogenous oxygen-binding heme protein predominantly expressed in central and peripheral neurons, plays a vital neuroprotective role by scavenging reactive oxygen and nitrogen species, preserving mitochondrial bioenergetics, and inhibiting intrinsic apoptotic pathways. However, clinical observations indicate that while NGB is transiently upregulated during early neurodegeneration as a compensatory response, its expression declines precipitously in advanced stages of AD and PD. To overcome the selective blood-brain barrier (BBB) and rapid systemic degradation of recombinant proteins, this conceptual review introduces two novel therapeutic frameworks: the Phyto-Exosomal Hybrid Neuroglobin System (PES-NGB), utilizing scalable plant-derived nanovesicles functionalized with neuron-homing rabies virus glycoprotein (RVG) peptides for non-invasive intranasal delivery; and the Redox-Gated Self-Amplifying Neuroglobin Circuit (RG-SANC), a circular RNA-based genetic switch engineered to restrict NGB synthesis exclusively to oxidatively stressed neurons. Furthermore, this article outlines a three-phase outpatient clinical protocol and a low-cost translational roadmap to make NGB-based neurotherapeutics accessible in resource-limited healthcare settings.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24335157
Primary Topic
Extracellular vesicles in disease
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Crossing the Blood-Brain Barrier for Neuroprotection: A Conceptual Review and Therapeutic Hypothesis on Exosome-Mediated Neuroglobin (NGB) Delivery in Alzheimer's and Parkinson's Diseases

Megha Ghosal
2 links
Zenodo (CERN European Organization for Nuclear Research)
Extracellular vesicles in disease
preprint

Crossing the Blood-Brain Barrier for Neuroprotection: A Conceptual Review and Therapeutic Hypothesis on Exosome-Mediated Neuroglobin (NGB) Delivery in Alzheimer's and Parkinson's Diseases

Megha Ghosal
preprint en

Abstract

Neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD), represent an escalating global health crisis characterized by progressive neuronal loss, oxidative stress, mitochondrial dysfunction, and pathological protein aggregation. Neuroglobin (NGB), an endogenous oxygen-binding heme protein predominantly expressed in central and peripheral neurons, plays a vital neuroprotective role by scavenging reactive oxygen and nitrogen species, preserving mitochondrial bioenergetics, and inhibiting intrinsic apoptotic pathways. However, clinical observations indicate that while NGB is transiently upregulated during early neurodegeneration as a compensatory response, its expression declines precipitously in advanced stages of AD and PD. To overcome the selective blood-brain barrier (BBB) and rapid systemic degradation of recombinant proteins, this conceptual review introduces two novel therapeutic frameworks: the Phyto-Exosomal Hybrid Neuroglobin System (PES-NGB), utilizing scalable plant-derived nanovesicles functionalized with neuron-homing rabies virus glycoprotein (RVG) peptides for non-invasive intranasal delivery; and the Redox-Gated Self-Amplifying Neuroglobin Circuit (RG-SANC), a circular RNA-based genetic switch engineered to restrict NGB synthesis exclusively to oxidatively stressed neurons. Furthermore, this article outlines a three-phase outpatient clinical protocol and a low-cost translational roadmap to make NGB-based neurotherapeutics accessible in resource-limited healthcare settings.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon